Cancer News and Research

Latest Cancer News and Research

World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with technetium-99m to detect cancerous lesions in men with prostate cancer.

31 Mar 2025

Patient navigators boost follow-up colonoscopies and reduce delays

A University of Arizona Health Sciences-led study found that patients are more likely to get colonoscopies following abnormal stool test results if patient navigators assist them through the process.

31 Mar 2025

New genetic discovery sheds light on PHTS-related vascular malformations

During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner.

31 Mar 2025

‘They won’t help me’: Sickest patients face insurance denials despite policy fixes

Sheldon Ekirch spends a lot of time on hold with her health insurance company. Sometimes, as the minutes tick by and her frustration mounts, Ekirch, 30, opens a meditation app on her phone. It was recommended by her psychologist to help with the depression associated with a stressful and painful medical disorder.

31 Mar 2025

Traditional Chinese medicine targets cholesterol metabolism for cancer treatment

Researchers explore how natural compounds in traditional Chinese medicine can modulate cholesterol metabolism to combat cancer.

31 Mar 2025

Can natural supplements backfire? Review explains how and why

A new review uncovers how common natural supplements can both protect and endanger health, depending on dose, duration, and delivery—and points to next-gen technologies as the key to unlocking their full therapeutic power.

31 Mar 2025

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of low-dose apixaban, experienced similar VTE recurrences and less bleeding as similar patients who received a full dose of the oral blood-thinning medication over the same extended period.

29 Mar 2025

Zero coronary artery calcium score predicts low heart risk at any age

Having a coronary artery calcium (CAC) score of zero has generally been accepted as a marker of a very low risk of having a cardiac event within the next five years. However, age is a strong contributor to coronary risk, with risk increasing markedly as people age.

29 Mar 2025

Owlstone Medical secures investment from Cystic Fibrosis Foundation

Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced that the Cystic Fibrosis Foundation has made an up to USD $2.3 million equity investment (circa £1.7 million) in Owlstone to develop a breath test for Pseudomonas aeruginosa (PA) detection in patients with cystic fibrosis (CF).

29 Mar 2025

Study uncovers how resistance to chemotherapies may occur in some cancers

Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells.

28 Mar 2025

Emory team takes heart disease research to the International Space Station

Heart disease remains the leading cause of death in the United States, accounting for one in five deaths.

28 Mar 2025

Studies explore bioactive compounds in plants for disease prevention

Fruits and plant extracts contain bioactive compounds that can help treat or prevent diseases. To characterize and understand their mechanism of action, researchers from universities and research institutions in Brazil and Germany have conducted independent but complementary studies.

28 Mar 2025

New phospholipids improve functional mRNA delivery via lipid nanoparticles

Researchers develop innovative phospholipids that improve the functional delivery of mRNA via lipid nanoparticles, paving the way for advanced therapeutic applications.

28 Mar 2025

Lipid accumulation in tumors linked to therapy resistance in breast cancer

A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.

28 Mar 2025

Research provides a comprehensive genomic and epigenomic landscape of ICE syndrome

Iridocorneal endothelial (ICE) syndrome is a rare, irreversibly blinding ocular disorder with an unknown etiology. Lack of targeted effective drugs, inadequate disease prognosis, and high relapse rates post-surgery are the current challenges of ICE.

28 Mar 2025

AI-powered model improves prediction of bladder cancer treatment outcomes

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

28 Mar 2025

Interval cancers account for significant breast cancer cases

In a new study, researchers from Karolinska Institutet have shown that so-called interval cancers, which are detected between two screening sessions, account for a significant proportion of breast cancer cases and that certain risk factors may increase the likelihood of developing this type of cancer.

28 Mar 2025

He had short-term health insurance. His colonoscopy bill: $7,000.

Tim Winard knew he needed to buy health insurance when he left his management job in manufacturing to launch his own business.

28 Mar 2025

Machine learning identifies key comorbidities predicting premature death in IBD patients

Researchers use machine learning models to investigate patterns between multimorbidity and premature deaths among decedents with irritable bowel disease.

28 Mar 2025

Expanded access to anti-obesity medications could boost life expectancy and save society billions

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a substantial societal return on investment, even after accounting for treatment costs.

27 Mar 2025

Cancer News and Research

Latest Cancer News and Research

World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

Patient navigators boost follow-up colonoscopies and reduce delays

New genetic discovery sheds light on PHTS-related vascular malformations

‘They won’t help me’: Sickest patients face insurance denials despite policy fixes

Traditional Chinese medicine targets cholesterol metabolism for cancer treatment

Can natural supplements backfire? Review explains how and why

Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients

Zero coronary artery calcium score predicts low heart risk at any age

Owlstone Medical secures investment from Cystic Fibrosis Foundation

Study uncovers how resistance to chemotherapies may occur in some cancers

Emory team takes heart disease research to the International Space Station

Studies explore bioactive compounds in plants for disease prevention

New phospholipids improve functional mRNA delivery via lipid nanoparticles

Lipid accumulation in tumors linked to therapy resistance in breast cancer

Research provides a comprehensive genomic and epigenomic landscape of ICE syndrome

AI-powered model improves prediction of bladder cancer treatment outcomes

Interval cancers account for significant breast cancer cases

He had short-term health insurance. His colonoscopy bill: $7,000.

Machine learning identifies key comorbidities predicting premature death in IBD patients

Expanded access to anti-obesity medications could boost life expectancy and save society billions

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in